Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$672.3M
+20.7% from 2023
Prescriptions
46K
$14,665.16 per claim
Patients
6,663
6,089 prescribers
Total spending, 2024
$672.4M
$100,866.96 per patient
Medicare prescription drug plans paid $672.3M for Promacta in 2024, for 45,844 prescriptions and refills to 6,663 patients (up 20.7% from 2023). The average cost per claim was $14,665.16.
California had the highest Medicare cost for Promacta in 2024: $72.9M for 5,311 claims, followed by New York ($58.8M).
Richards Afonja, hematology-oncology in Clifton, NJ, had the highest Medicare cost for Promacta in 2024: 203 claims costing $2.4M.
Promacta is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Richards Afonja Clifton, NJ | Hematology-Oncology | 203 | 27 | $2.4M |
| Todd D Shenkenberg Harlingen, TX | Medical Oncology | 146 | 24 | $1.6M |
| Paola M Barragan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,776 | 35,692 | 5,150 | $454.8M |
| 2023 | 5,299 | 39,485 | 5,702 | $557.1M |
| 2024 | 6,089 | 45,844 | 6,663 | $672.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 58 |
| Under 11 |
| $1.6M |
| Wahid T Hanna Knoxville, TN | Hematology-Oncology | 84 | Under 11 | $1.4M |
| Yogenthiran Saunthararajah Cleveland, OH | Hematology | 35 | Under 11 | $1.3M |
| Alexis M Cruz-Chacon San Juan, PR | Hematology-Oncology | 35 | Under 11 | $1.3M |
| Leonard C Alsfeld Charleston, SC | Hematology | 60 | 12 | $1.2M |
| Michael W Drazer Chicago, IL | Hematology-Oncology | 39 | Under 11 | $1.2M |
| Monica Mendez Ayala Manati, PR | Hematology-Oncology | 86 | 14 | $1.1M |
| John C Hughes Saginaw, MI | Hematology-Oncology | 68 | Under 11 | $1.1M |
| Nancy Giallombardo Boston, MA | Nurse Practitioner | 30 | Under 11 | $1.1M |
| Rookmini Singh New York, NY | Nurse Practitioner | 29 | Under 11 | $1.0M |
| Liza M Paulo Malave Aguadilla, PR | Hematology-Oncology | 112 | 11 | $996K |
| Elias N Kiwan Sacramento, CA | Hematology-Oncology | 62 | Under 11 | $995K |
| Vincent E Herrin Jackson, MS | Hematology-Oncology | 27 | Under 11 | $991K |
| Amy Y Kuo Stanford, CA | Nurse Practitioner | 42 | Under 11 | $985K |
| Shannon Robinson Buffalo, NY | Nurse Practitioner | 43 | Under 11 | $946K |
| Yiwu Huang Brooklyn, NY | Hematology-Oncology | 23 | Under 11 | $944K |
| Jose B Melo Plantation, FL | Hematology-Oncology | 65 | Under 11 | $941K |
| Michael J McCleod Fort Myers, FL | Hematology-Oncology | 25 | Under 11 | $909K |
| Abdulraheem Yacoub Westwood, KS | Hematology-Oncology | 37 | Under 11 | $889K |
| Jimmy E Fong Jr. Duarte, CA | Nurse Practitioner | 40 | Under 11 | $883K |
| Hyunhee Yoon New York, NY | Nurse Practitioner | 31 | Under 11 | $879K |
| Neil C Dunavin Zion, IL | Hematology | 30 | Under 11 | $868K |
| Erick G Cruz Mayaguez, PR | Hematology-Oncology | 82 | Under 11 | $853K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 45,852 | $672.4M |